Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Neoleukin Therapeutics stock | $10.03

Learn how to easily invest in Neoleukin Therapeutics stock.

Neoleukin Therapeutics, Inc
NASDAQ: NLTX - USD
DRUG MANUFACTURERS-SPECIALTY & GENERIC
$6.80
-$0.38 (-5.29%)

Neoleukin Therapeutics, Inc is a drug manufacturers-specialty & generic business based in the US. Neoleukin Therapeutics shares (NLTX) are listed on the NASDAQ and all prices are listed in US Dollars. Neoleukin Therapeutics employs 78 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy shares in Neoleukin Therapeutics

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – NLTX – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Neoleukin Therapeutics stock price (NASDAQ: NLTX)

Use our graph to track the performance of NLTX stocks over time.

Neoleukin Therapeutics shares at a glance

Information last updated 2021-07-31.
Latest market close$10.03
52-week range$6.92 - $17.95
50-day moving average $9.14
200-day moving average $11.30
Wall St. target price$20.40
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.94

Buy Neoleukin Therapeutics shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Robinhood
Stocks, Options, ETFs
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Sofi Invest
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Public
Stocks, ETFs
N/A
$0 per month
Download and sign up with Public.com; approved accounts receive a free stock slice worth up to $70, selected from 9 popular stocks.
Open an account
Commission-free trading in stocks and ETFs with a social networking twist.
Webull
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $3.00 and $300 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
0%
N/A
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Moomoo
Stocks, Options, ETFs
$0
$0 per year
N/A
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Neoleukin Therapeutics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Neoleukin Therapeutics price performance over time

Historical closes compared with the close of $10.03 from 2021-05-28

1 week (2021-07-24) N/A
1 month (2021-07-02) 4.48%
3 months (2021-05-04) -11.40%
6 months (2021-01-31) N/A
1 year (2020-07-31) N/A
2 years (2019-07-31) N/A
3 years (2018-07-31) N/A
5 years (2016-07-31) N/A

Neoleukin Therapeutics financials

Gross profit TTM $0
Return on assets TTM -16.79%
Return on equity TTM -25.05%
Profit margin 0%
Book value $4.23
Market capitalisation $296 million

TTM: trailing 12 months

Shorting Neoleukin Therapeutics shares

There are currently 2.1 million Neoleukin Therapeutics shares held short by investors – that's known as Neoleukin Therapeutics's "short interest". This figure is 0.1% up from 2.1 million last month.

There are a few different ways that this level of interest in shorting Neoleukin Therapeutics shares can be evaluated.

Neoleukin Therapeutics's "short interest ratio" (SIR)

Neoleukin Therapeutics's "short interest ratio" (SIR) is the quantity of Neoleukin Therapeutics shares currently shorted divided by the average quantity of Neoleukin Therapeutics shares traded daily (recently around 207564.91935484). Neoleukin Therapeutics's SIR currently stands at 9.92. In other words for every 100,000 Neoleukin Therapeutics shares traded daily on the market, roughly 9920 shares are currently held short.

However Neoleukin Therapeutics's short interest can also be evaluated against the total number of Neoleukin Therapeutics shares, or, against the total number of tradable Neoleukin Therapeutics shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Neoleukin Therapeutics's short interest could be expressed as 0.05% of the outstanding shares (for every 100,000 Neoleukin Therapeutics shares in existence, roughly 50 shares are currently held short) or 0.0949% of the tradable shares (for every 100,000 tradable Neoleukin Therapeutics shares, roughly 95 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Neoleukin Therapeutics.

Find out more about how you can short Neoleukin Therapeutics stock.

Neoleukin Therapeutics share dividends

We're not expecting Neoleukin Therapeutics to pay a dividend over the next 12 months.

Neoleukin Therapeutics share price volatility

Over the last 12 months, Neoleukin Therapeutics's shares have ranged in value from as little as $6.92 up to $17.95. A popular way to gauge a stock's volatility is its "beta".

NLTX.US volatility(beta: 0.97)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Neoleukin Therapeutics's is 0.9744. This would suggest that Neoleukin Therapeutics's shares are less volatile than average (for this exchange).

Neoleukin Therapeutics overview

Neoleukin Therapeutics, Inc. , a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of various types of cancer, including renal cell carcinoma and melanoma. The company was formerly known as Aquinox Pharmaceuticals, Inc. and changed its name to Neoleukin Therapeutics, Inc. in August 2019. Neoleukin Therapeutics, Inc.

Stocks similar to Neoleukin Therapeutics

Frequently asked questions

What percentage of Neoleukin Therapeutics is owned by insiders or institutions?
Currently 22.339% of Neoleukin Therapeutics shares are held by insiders and 68.194% by institutions.
How many people work for Neoleukin Therapeutics?
Latest data suggests 78 work at Neoleukin Therapeutics.
When does the fiscal year end for Neoleukin Therapeutics?
Neoleukin Therapeutics's fiscal year ends in December.
Where is Neoleukin Therapeutics based?
Neoleukin Therapeutics's address is: 1616 Eastlake Avenue East, Seattle, WA, United States, 98102
What is Neoleukin Therapeutics's ISIN number?
Neoleukin Therapeutics's international securities identification number is: US64049K1043
What is Neoleukin Therapeutics's CUSIP number?
Neoleukin Therapeutics's Committee on Uniform Securities Identification Procedures number is: 03842B101

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site